Literature DB >> 10508879

Fetal membrane histology in preterm premature rupture of membranes: comparison to controls, and between antibiotic and placebo treatment. The National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network, Bethesda, MD, USA.

R W Bendon1, O Faye-Petersen, Z Pavlova, F Qureshi, B Mercer, M Miodovnik, A F Das, P J Meis, A H Moawad, J D Iams, D McNellis.   

Abstract

The objectives of this study were to test the hypotheses that antibiotic therapy will alter the histologic appearance of fetal membranes in preterm premature rupture of membranes (pPROM), and that the membrane histology will demonstrate distinct differences between term and preterm rupture of membranes. We also wished to test interobserver variability of pathologists. Placental membranes were sampled from 268 women participating in a randomized placebo-controlled trial of antibiotic therapy for pPROM at 24-32 weeks of gestation (cases) and from 4 control groups who were not in the randomized trial: (1) preterm labor without pPROM (n = 21), (2) term labor (n = 65), (3) term PROM (n = 21), and (4) term cesarean section (n = 27). The cases and controls were scored for 40 histologic features by pathologists blinded to the identity of each sample (case or control). pPROM histology of samples from patients receiving antibiotics and those receiving placebo was compared using a chi-squared test and with control groups using logistic regression. There were no histological differences between pPROM cases treated with antibiotic and those receiving placebo, nor with respect to duration of membrane rupture greater or less than 48 h. Concordance among pathologists was low for features other than acute inflammation. Logistic regression analysis controlled for race and pathologist, and demonstrated that all of the control groups had significantly fewer common markers of acute inflammation when compared with the pPROM cases. This study suggests that histopathologic evidence of infection is seen more frequently with pPROM than in preterm or term controls. The histologic features used in this study cannot be used to determine the effectiveness of antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508879     DOI: 10.1007/s100249900161

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  8 in total

1.  The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes.

Authors:  Brian M Mercer; Dennis T Crouse; Robert L Goldenberg; Menachem Miodovnik; Delicia C Mapp; Paul J Meis; Mitchell P Dombrowski
Journal:  Am J Obstet Gynecol       Date:  2011-09-08       Impact factor: 8.661

2.  A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM).

Authors:  Roberto Romero; Lara A Friel; Digna R Velez Edwards; Juan Pedro Kusanovic; Sonia S Hassan; Shali Mazaki-Tovi; Edi Vaisbuch; Chong Jai Kim; Offer Erez; Tinnakorn Chaiworapongsa; Brad D Pearce; Jacquelaine Bartlett; Benjamin A Salisbury; Madan Kumar Anant; Gerald F Vovis; Min Seob Lee; Ricardo Gomez; Ernesto Behnke; Enrique Oyarzun; Gerard Tromp; Scott M Williams; Ramkumar Menon
Journal:  Am J Obstet Gynecol       Date:  2010-07-31       Impact factor: 8.661

3.  A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM.

Authors:  JoonHo Lee; Roberto Romero; Sun Min Kim; Piya Chaemsaithong; Chan-Wook Park; Joong Shin Park; Jong Kwan Jun; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-09-16

4.  Compensatory fetal membrane mechanisms between biglycan and decorin in inflammation.

Authors:  Luciana Batalha de Miranda de Araujo; Casie E Horgan; Abraham Aron; Renato V Iozzo; Beatrice E Lechner
Journal:  Mol Reprod Dev       Date:  2015-04-23       Impact factor: 2.609

5.  A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in patients with preterm PROM.

Authors:  JoonHo Lee; Roberto Romero; Sun Min Kim; Piya Chaemsaithong; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-02

6.  Perinatal Outcome in Pregnancies with Extreme Preterm Premature Rupture of Membranes (Mid-Trimester PROM).

Authors:  Nihal Al-Riyami; Fatma Al-Shezawi; Intisar Al-Ruheili; Tamima Al-Dughaishi; Murtadha Al-Khabori
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

7.  Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) Trial [ISRCTN44485060].

Authors:  Jonathan M Morris; Christine L Roberts; Caroline A Crowther; Sarah L Buchanan; David J Henderson-Smart; Glenn Salkeld
Journal:  BMC Pregnancy Childbirth       Date:  2006-03-23       Impact factor: 3.007

8.  The association between increased maternal PARK7 (DJ-1) levels and the occurrence of preterm premature rupture of membranes - A randomized prospective study

Authors:  Uğur Turhan; Burak Tatar
Journal:  Turk J Obstet Gynecol       Date:  2021-12-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.